Page last updated: 2024-10-30

leflunomide and Apoplexy

leflunomide has been researched along with Apoplexy in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Maljaars, J1
Ortega-Gutierrez, S1
Cho, T1
Shaban, A1

Other Studies

1 other study available for leflunomide and Apoplexy

ArticleYear
Q Fever, CNS Vasculitis, and Stroke: A Case Report.
    The American journal of medicine, 2020, Volume: 133, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Arthritis, Rheumatoid; Cholestyramine Resin; Humans; Leflunomide; Male

2020